These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9869585)

  • 1. Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis.
    Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1999 Jan; 43(1):166-8. PubMed ID: 9869585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
    Malathum K; Coque TM; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
    Hoppe JE; Bryskier A
    Antimicrob Agents Chemother; 1998 Apr; 42(4):965-6. PubMed ID: 9559823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
    Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1037-41. PubMed ID: 9145865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains.
    Biedenbach DJ; Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):349-53. PubMed ID: 9635909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).
    Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2019-22. PubMed ID: 9303406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Mar; 42(3):624-30. PubMed ID: 9517943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
    Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.
    Boswell FJ; Andrews JM; Ashby JP; Fogarty C; Brenwald NP; Wise R
    J Antimicrob Chemother; 1998 Dec; 42(6):703-9. PubMed ID: 10052892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae.
    Engler KH; Warner M; George RC
    J Antimicrob Chemother; 2001 Jan; 47(1):27-31. PubMed ID: 11152428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
    Baltch AL; Smith RP; Ritz WJ; Bopp LH
    Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
    Jamjian C; Biedenbach DJ; Jones RN
    Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
    Nagai K; Davies TA; Ednie LM; Bryskier A; Palavecino E; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci.
    Wootton M; Bowker KE; Janowska A; Holt HA; MacGowan AP
    J Antimicrob Chemother; 1999 Oct; 44(4):445-53. PubMed ID: 10588304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1998 Jun; 41(6):649-53. PubMed ID: 9687104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):767-9. PubMed ID: 9405952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of HMR 3647 against anaerobic bacteria.
    Edlund C; Sillerström E; Wahlund E; Nord CE
    J Chemother; 1998 Aug; 10(4):280-4. PubMed ID: 9720465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay.
    Pankuch GA; Hoellman DB; Lin G; Bajaksouzian S; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3032-4. PubMed ID: 9797250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.